AstraZeneca (AZN) News Today $65.35 +0.91 (+1.41%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZNDecember 20 at 11:44 PM | investing.comAnalysts are saying the AstraZeneca share price looks cheap despite China turmoilDecember 20 at 8:06 AM | msn.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZNDecember 19 at 11:46 PM | markets.businessinsider.comAstraZeneca (AZN) Shares Fall After Reports of PRC Probe Alleged Fraud and Corruption – Hagens BermanDecember 19 at 1:24 PM | globenewswire.comAstraZeneca Digital Transformation Strategy Profile 2024 - Accelerators, Incubators and Innovation ProgramsDecember 19 at 5:18 AM | globenewswire.comAstraZeneca PLC Announcement: If You Have Suffered Losses in AstraZeneca PLC (NASDAQ: AZN), You Are Encouraged to Contact The Rosen Law Firm About Your RightsDecember 18 at 7:15 PM | globenewswire.comRosen Law Firm Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZNDecember 17, 2024 | prnewswire.comIs AstraZeneca PLC (AZN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?December 17, 2024 | insidermonkey.comRosen Law Firm Encourages AstraZeneca PLC Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – AZNDecember 16, 2024 | businesswire.comAstraZeneca (AZN) Shares Fall After Reports of PRC Probe Alleged Fraud and Corruption – Hagens BermanDecember 16, 2024 | globenewswire.comAstraZeneca Strengthens Board with New Non-Executive Director AppointmentsDecember 16, 2024 | markets.businessinsider.comShort Interest in AstraZeneca PLC (NASDAQ:AZN) Drops By 8.3%AstraZeneca PLC (NASDAQ:AZN - Get Free Report) was the target of a large decrease in short interest in November. As of November 30th, there was short interest totalling 7,400,000 shares, a decrease of 8.3% from the November 15th total of 8,070,000 shares. Based on an average daily volume of 5,350,000 shares, the short-interest ratio is presently 1.4 days.December 16, 2024 | marketbeat.com3 Unstoppable Stocks to Buy Right NowDecember 15, 2024 | fool.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by State Street CorpState Street Corp cut its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 22.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,817,624 shares of the company's stock after selling 511,916 shares during the quarter. StateDecember 15, 2024 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Peapack Gladstone Financial CorpPeapack Gladstone Financial Corp raised its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 18.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 149,605 shares of the company's stock after buying an additional 23,159 shareDecember 14, 2024 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Verition Fund Management LLCVerition Fund Management LLC lowered its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 66.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,337 shares of the company's stock afterDecember 14, 2024 | marketbeat.comFranklin Resources Inc. Acquires 1,522,715 Shares of AstraZeneca PLC (NASDAQ:AZN)Franklin Resources Inc. raised its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 19,122,675 shares of the company's stock after buying an additional 1,December 13, 2024 | marketbeat.comWilmington Savings Fund Society FSB Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)Wilmington Savings Fund Society FSB bought a new position in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 71,647 shares of the company's stock, valued at approximately $December 13, 2024 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Holdings Lowered by Vestcor IncVestcor Inc trimmed its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 43.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 13,100 shares of the company's stock after selling 10,100 shares during the peDecember 13, 2024 | marketbeat.comTracer Biotechnologies Announces Agreement for Next-Generation Cancer Monitoring for Drug DevelopmentDecember 12, 2024 | businesswire.comVirtu Financial LLC Takes $4.82 Million Position in AstraZeneca PLC (NASDAQ:AZN)Virtu Financial LLC bought a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 61,897 shares of the company's stock, valued at approximately $4,822,000December 12, 2024 | marketbeat.comAdvisory Resource Group Takes $946,000 Position in AstraZeneca PLC (NASDAQ:AZN)Advisory Resource Group purchased a new stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 12,143 shares of the company's stock, valued at approximately $946,000. A number of oDecember 12, 2024 | marketbeat.comTD Cowen Keeps Their Buy Rating on AstraZeneca (AZN)December 12, 2024 | markets.businessinsider.comAstraZeneca (AZN) Shares Fall After Reports of PRC Probe Alleged Fraud and Corruption – Hagens BermanDecember 11, 2024 | globenewswire.comAstraZeneca rises Wednesday, still underperforms marketDecember 11, 2024 | marketwatch.comAstraZeneca, Merck report positive long-term data for LynparzaDecember 11, 2024 | seekingalpha.comTeachers Retirement System of The State of Kentucky Trims Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Teachers Retirement System of The State of Kentucky cut its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 1.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 506,072 shares of thDecember 11, 2024 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Purchased by National Bank of Canada FINational Bank of Canada FI raised its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 53.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 158,329 shares of the company's stock after acquiring an additional 55,47December 11, 2024 | marketbeat.comAstraZeneca’s (AZN) Struggles: Cramer’s Disappointment and Challenges in ChinaDecember 10, 2024 | msn.comGroupama Asset Managment Purchases 101,225 Shares of AstraZeneca PLC (NASDAQ:AZN)Groupama Asset Managment increased its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 22.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 543,398 shares of the company's stock after buying an additionDecember 10, 2024 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Y Intercept Hong Kong LtdY Intercept Hong Kong Ltd increased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 91.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 38,688 shares of the company's stock after purchasing an additiDecember 10, 2024 | marketbeat.comMML Investors Services LLC Raises Stock Position in AstraZeneca PLC (NASDAQ:AZN)MML Investors Services LLC lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 3.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 255,605 shares of the company's stock afterDecember 10, 2024 | marketbeat.comKovitz Investment Group Partners LLC Has $2.08 Million Position in AstraZeneca PLC (NASDAQ:AZN)Kovitz Investment Group Partners LLC boosted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 138.0% in the third quarter, according to its most recent filing with the SEC. The firm owned 26,755 shares of the company's stock after acquiring an additional 15,515 shares duringDecember 10, 2024 | marketbeat.comDown 20% in 14 weeks, is AstraZeneca’s share price now too big a bargain for me to miss?December 10, 2024 | msn.comWhere might the AstraZeneca share price go in 2025? Here’s what the experts forecastDecember 9, 2024 | msn.comInsider Stock Buying Reaches US$2.58m On AstraZenecaDecember 8, 2024 | uk.finance.yahoo.comCentiva Capital LP Buys New Shares in AstraZeneca PLC (NASDAQ:AZN)Centiva Capital LP purchased a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 7,551 shares of the company's stock, valued at approximateDecember 8, 2024 | marketbeat.comAstraZeneca sBLA for Imfinzi granted Priority Review in MIBCDecember 6, 2024 | markets.businessinsider.comWellington Management Group LLP Sells 3,322,834 Shares of AstraZeneca PLC (NASDAQ:AZN)Wellington Management Group LLP reduced its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 37,247,083 shares of the company's stock after selling 3,December 6, 2024 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Soros Fund Management LLCSoros Fund Management LLC lifted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,652,771 shares of the company's stock after purchasingDecember 6, 2024 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Stifel Financial CorpStifel Financial Corp raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 6.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,348,904 shares of the company's stock afteDecember 6, 2024 | marketbeat.comQuantinno Capital Management LP Raises Holdings in AstraZeneca PLC (NASDAQ:AZN)Quantinno Capital Management LP lifted its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 17.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 140,596 shares of the company's stock after buying an additional 20December 6, 2024 | marketbeat.comDatopotamab Deruxtecan Demonstrated Meaningful Clinical Activity in Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer in TROPION-Lung05 and TROPION-Lung01 Pooled AnalysisDecember 5, 2024 | businesswire.comAstraZeneca announces FDA approval for ImfinziDecember 5, 2024 | markets.businessinsider.comFDA Approves AstraZeneca's Blockbuster Cancer Drug Imfinzi For Aggressive Form Of Lung CancerDecember 5, 2024 | finance.yahoo.comAstraZeneca’s Imfinzi approved in U.S. as immunotherapy regimen for LS-SCLCDecember 5, 2024 | markets.businessinsider.comAstraZeneca: FDA Approves Imfinzi To Treat Adult Patients With Limited-stage Small Cell Lung CancerDecember 5, 2024 | markets.businessinsider.comJanus Henderson Group PLC Acquires 85,502 Shares of AstraZeneca PLC (NASDAQ:AZN)Janus Henderson Group PLC lifted its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 5.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,669,554 shares of the company's stock after purchasing an additional 85,502 shares during the perDecember 5, 2024 | marketbeat.comHilltop Holdings Inc. Takes Position in AstraZeneca PLC (NASDAQ:AZN)Hilltop Holdings Inc. purchased a new stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 9,368 shares of the company's stock, valued at approDecember 5, 2024 | marketbeat.comFDA approves AstraZeneca's Imfinzi for limited-stage small cell lung cancerDecember 4, 2024 | reuters.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You See Trump’s Bombshell Exec. Order 001? (Ad)Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.460.61▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼1519▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novo Nordisk A/S News Novartis News Sanofi News GSK News Takeda Pharmaceutical News BioNTech News Teva Pharmaceutical Industries News BeiGene News Moderna News Viatris News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZN Stock Alerts